405억원 확보! 삼성제약의 성공적인 유상증자 한국의 제약 기업 중 하나인 삼성제약이 최근 유상증자를 통해 405억원을 확보했다는 소식이 전해졌습니다. 이번 유상증자는 삼성제약의 성장을 더욱 가속화시킬 것으로
405 . . .
405 ! .
.
405 .
405 ! . . .
Comment reported successfully.
Post was successfully added to your timeline!
You have reached your limit of 5000 friends!
File size error: The file exceeds allowed the limit (46 MB) and can not be uploaded.
Unable to upload a file: This file type is not supported.
We have detected some adult content on the image you uploaded, therefore we have declined your upload process.
To upload images, videos, and audio files, you have to upgrade to pro member. Upgrade To Pro